Our study demonstrates that most urothelial carcinomas have more CD8+ cytotoxic T cells at the IM than in the CT and that this particularly applies to small-cell bladder cancers. The gene discussed is CD8A; the disease is urinary bladder small cell neuroendocrine carcinoma.